Efficacy and safety of the tree sublingual immunotherapy tablet in the subpopulation of Canadian children with allergic rhinitis and/or conjunctivitis: phase III trial results

ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY · Published 2026-07-11 · DOI 10.1186/s13223-026-01054-w

Free full text

Authors (5)

Rémi Gagnon, Terrie Dalgaard, Gry Schermann Ortving, Monika Gappa, Hendrik Nolte

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Gagnon, R., Dalgaard, T., Ortving, G., et al. (2026). Efficacy and safety of the tree sublingual immunotherapy tablet in the subpopulation of Canadian children with allergic rhinitis and/or conjunctivitis: phase III trial results. ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY. https://doi.org/10.1186/s13223-026-01054-w

Related articles